Brain Tumor Treatments: Minnesota
Sponsored By
Brain tumor book
Please Click On The Above Banner For More Details

[Click HERE to print this page!]
Braintumor Website

Search Term: Minnesota
Please scroll down to see the matching trials.

  (0.8510)   Brain Tumor Survivor Stories
  (0.8351)   Advanced Search
  (0.8169)   Brain Tumor Treatments: Minnesota
  (0.7742)   Untitled Document
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Virtualtrials Newsletter

Sorry - There were no pages found that contain that search phrase.



  Treatment Location Last Updated
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Saint Louis Park, MN USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Edina, MN USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Robbinsdale, MN USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Minneapolis, MN USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Saint Louis Park, MN USA 04/11/2008
Details Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme Rochester, MN USA 03/02/2008
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Rochester, MN USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Saint Louis Park, MN USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Rochester, MN USA 05/01/2007
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Saint Louis Park, MN USA 05/01/2007
Details Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas Rochester, MN USA 05/01/2007
Details Phase I/II Study of Sorafenib and Temsirolimus in Patients With Recurrent Glioblastoma Rochester, MN USA 04/28/2007
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Minneapolis, MN USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Rochester, MN USA 10/12/2006
Details Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Saint Cloud, MN USA 06/26/2006
Details Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Rochester, MN USA 06/26/2006
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Saint Louis Park, MN USA 06/26/2006
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Rochester, MN USA 06/26/2006
Details Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Saint Louis Park, MN USA 06/26/2006
Details Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Rochester, MN USA 06/26/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Rochester, MN USA 05/30/2006
Details A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron) for Plexiform Neurofibromas (NF1 patients) St. Paul, MN USA 12/04/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Rochester, MN USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Duluth, MN USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Minneapolis, MN USA 11/27/2005
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Duluth, MN USA 11/27/2005
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Saint Louis Park, MN USA 11/27/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Minneapolis, MN USA 11/26/2005
Details Thalomidâ„¢ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma Minneapolis, MN USA 11/26/2005
Details Thalomidâ„¢ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma St. Paul, MN USA 11/26/2005
Details Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors Minneapolis, MN USA 11/21/2005
Details A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection Minneapolis, MN USA 11/13/2005
Details FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia Rochester, MN USA 11/11/2005
Details FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia Minneapolis, MN USA 11/11/2005
Details Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Rochester, MN USA 11/11/2005
Details Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Minneapolis, MN USA 11/11/2005
Details Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Rochester, MN USA 11/06/2005



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Gliadel® Wafer | Temodar®
Fundraising For Research | Unsubscribe | Feedback | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE

Copyright (c) 1993 - 2008 by The Musella Foundation

Website Design By
World Wide Websites